chr17-40140747-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_007359.5(CASC3):āc.199G>Cā(p.Gly67Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000216 in 1,527,996 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00012 ( 0 hom., cov: 29)
Exomes š: 0.000011 ( 0 hom. )
Consequence
CASC3
NM_007359.5 missense
NM_007359.5 missense
Scores
3
4
12
Clinical Significance
Conservation
PhyloP100: 4.38
Genes affected
CASC3 (HGNC:17040): (CASC3 exon junction complex subunit) The product of this gene is a core component of the exon junction complex (EJC), a protein complex that is deposited on spliced mRNAs at exon-exon junctions and functions in nonsense-mediated mRNA decay (NMD). The encoded protein binds RNA and interacts with two other EJC core components. It is predominantly located in the cytoplasm, but shuttles into the nucleus where it localizes to nuclear speckles. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.28929073).
BS2
High AC in GnomAd4 at 18 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CASC3 | NM_007359.5 | c.199G>C | p.Gly67Arg | missense_variant | 1/14 | ENST00000264645.12 | |
CASC3 | XM_005257163.3 | c.199G>C | p.Gly67Arg | missense_variant | 1/14 | ||
CASC3 | XM_047435623.1 | c.199G>C | p.Gly67Arg | missense_variant | 1/9 | ||
CASC3 | XM_047435624.1 | c.-767G>C | 5_prime_UTR_variant | 1/15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CASC3 | ENST00000264645.12 | c.199G>C | p.Gly67Arg | missense_variant | 1/14 | 1 | NM_007359.5 | P1 | |
CASC3 | ENST00000418132.7 | n.430G>C | non_coding_transcript_exon_variant | 1/8 | 1 | ||||
CASC3 | ENST00000581849.1 | n.211G>C | non_coding_transcript_exon_variant | 1/4 | 2 | ||||
CASC3 | ENST00000583649.1 | n.204G>C | non_coding_transcript_exon_variant | 1/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000119 AC: 18AN: 151620Hom.: 0 Cov.: 29
GnomAD3 genomes
AF:
AC:
18
AN:
151620
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000246 AC: 3AN: 122174Hom.: 0 AF XY: 0.0000152 AC XY: 1AN XY: 65678
GnomAD3 exomes
AF:
AC:
3
AN:
122174
Hom.:
AF XY:
AC XY:
1
AN XY:
65678
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000109 AC: 15AN: 1376376Hom.: 0 Cov.: 34 AF XY: 0.00000886 AC XY: 6AN XY: 677358
GnomAD4 exome
AF:
AC:
15
AN:
1376376
Hom.:
Cov.:
34
AF XY:
AC XY:
6
AN XY:
677358
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000119 AC: 18AN: 151620Hom.: 0 Cov.: 29 AF XY: 0.000108 AC XY: 8AN XY: 74064
GnomAD4 genome
AF:
AC:
18
AN:
151620
Hom.:
Cov.:
29
AF XY:
AC XY:
8
AN XY:
74064
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 06, 2023 | The c.199G>C (p.G67R) alteration is located in exon 1 (coding exon 1) of the CASC3 gene. This alteration results from a G to C substitution at nucleotide position 199, causing the glycine (G) at amino acid position 67 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Pathogenic
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
MutationTaster
Benign
D
PrimateAI
Pathogenic
D
PROVEAN
Benign
N
REVEL
Benign
Sift
Uncertain
D
Sift4G
Benign
T
Polyphen
D
Vest4
MutPred
Gain of MoRF binding (P = 0.0249);
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at